HLA Stock Overview

Healthia Limited provides health services in Australia. More details

HLA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	3/6
Dividends	2/6

Rewards

Became profitable this year

Risk Analysis

Large one-off items impacting financial results

Has a high level of debt

My Notes

Capture your thoughts, links and company narrative

Healthia Limited Competitors

SILK Laser Australia

ASX:SLA

AU$177.4m

Apiam Animal Health

ASX:AHX

AU$68.4m

Australian Clinical Labs

ASX:ACL

AU$685.1m

Pacific Smiles Group

ASX:PSQ

AU$311.6m

Price History & Performance

Summary of share price highs, lows and changes for Healthia
Historical stock prices
Current Share Price	AU$1.80
52 Week High	AU$1.80
52 Week Low	AU$0.85
Beta	1.08
1 Month Change	1.13%
3 Month Change	3.16%
1 Year Change	63.18%
3 Year Change	n/a
5 Year Change	57.46%
Change since IPO	41.90%

Recent updates

Shareholder Returns

	HLA	AU Healthcare	AU Market
7D	0.1%	-4.4%	-2.7%
1Y	63.2%	-7.5%	6.5%

Return vs Industry: HLA exceeded the Australian Healthcare industry which returned -11% over the past year.

Return vs Market: HLA exceeded the Australian Market which returned -0.5% over the past year.

Price Volatility

Is HLA's price volatile compared to industry and market?
HLA volatility
HLA Average Weekly Movement	0.6%
Healthcare Industry Average Movement	5.6%
Market Average Movement	8.0%
10% most volatile stocks in AU Market	16.8%
10% least volatile stocks in AU Market	3.1%

Stable Share Price: HLA's share price has been volatile over the past 3 months.

Volatility Over Time: HLA's weekly volatility has decreased from 14% to 1% over the past year.

About the Company

Founded	Employees	CEO	Website
2018	n/a	Wes Coote	www.healthia.com.au

Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices.

Healthia Limited Fundamentals Summary

How do Healthia's earnings and revenue compare to its market cap?
HLA fundamental statistics
Market cap	AU$252.06m
Earnings (TTM)	AU$5.47m
Revenue (TTM)	AU$252.56m

46.1x

P/E Ratio

1.0x

P/S Ratio

Is HLA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLA income statement (TTM)
Revenue	AU$252.56m
Cost of Revenue	AU$175.80m
Gross Profit	AU$76.75m
Other Expenses	AU$71.29m
Earnings	AU$5.47m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.039
Gross Margin	30.39%
Net Profit Margin	2.16%
Debt/Equity Ratio	50.7%

How did HLA perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

85%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/12/04 21:07
End of Day Share Price	2023/11/30 00:00
Earnings	2023/06/30
Annual Earnings	2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Healthia Limited is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Russell Wright	Barclay Pearce Capital Pty Limited
Warren Jeffries	Canaccord Genuity
Wilson Wong	Jarden Limited

HLA Stock Overview

Rewards

Risk Analysis

Healthia Limited Competitors

ASX:SLA

AU$177.4m

ASX:AHX

AU$68.4m

ASX:ACL

AU$685.1m

ASX:PSQ

AU$311.6m

Price History & Performance

Recent News & Updates

Healthia Limited Announces Board Changes

Full year 2023 earnings released: EPS: AU$0.04 (vs AU$0.028 loss in FY 2022)

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

New major risk - Financial position

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Recent updates

Healthia Limited Announces Board Changes

Full year 2023 earnings released: EPS: AU$0.04 (vs AU$0.028 loss in FY 2022)

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

New major risk - Financial position

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Healthia Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.03 (vs AU$0.001 loss in 1H 2022)

Healthia Limited (ASX:HLA) agreed to acquire Kosmac & Clemens Optometrists.

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought AU$85k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of Corio Bay Health Group.

Less than half of directors are independent

Healthia Limited (ASX:HLA) acquired Watsonia Physiotherapy.

Healthia Limited, Annual General Meeting, Nov 23, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Corio Bay Health Group.

Full year 2022 earnings released: AU$0.028 loss per share (vs AU$0.065 profit in FY 2021)

Healthia Limited Determines Not to Declare the Payment of A Final Dividend for 2022

Healthia Limited to Report Fiscal Year 2022 Results on Aug 31, 2022

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Healthia Limited Announces Board Changes

Board Member recently sold AU$52k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Healthia Limited Announces Dividend on HLA - ORDINARY FULLY PAID for the Six Months Ended 31 Dec. 2021, Payable on 24 March 2022

Healthia Limited Recommends Interim Dividend, Payable on March 22, 2022

Healthia Limited to Report First Half, 2022 Results on Feb 28, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Mornington Peninsula Family Physiotherapy.

Board Member recently bought AU$64k worth of stock

Healthia Limited has completed a Follow-on Equity Offering in the amount of AUD 22.268376 million.

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.043 in FY 2020)

Investor sentiment improved over the past week

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire John Holme Optometrist Mareeba.

Healthia Limited (ASX:HLA) agreed to acquire The Eyecare Place for AUD 0.62 million.

Healthia Limited (ASX:HLA) completed the acquisition of Sandringham Sports Physio.

Independent Non-Executive Director recently bought AU$96k worth of stock

Healthia Limited (ASX:HLA) acquired 4 physiotherapy clinics for AUD 1.3 million.

Healthia Limited (ASX:HLA) completed the acquisition of The Physio Clinic for AUD 2 million.

Investor sentiment improved over the past week

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire The Physio Clinic for AUD 2 million.

Healthia Limited (ASX:HLA) completed the acquisition of The Optical Company Pty Ltd from Kangisser Family Trust and Chester Capital Investment Trust.

Healthia Limited (ASX:HLA) entered into an binding agreement to acquire The Optical Company Pty Ltd from Kangisser Family Trust and Chester Capital Investment Trust for AUD 43.8 million.

Healthia Limited (ASX:HLA) entered into a binding agreement to acquire North Queensland Physiotherapy Centre for AUD 1.7 million.

Group COO & Executive Director recently sold AU$197k worth of stock

Non-Executive Chairman recently bought AU$52k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of 4 specialty hand therapy clinics in Sydney.

Healthia Limited (ASX:HLA) entered into agreement to acquire 3 Physiotherapy Clinics in Queensland and 1 Podiatry clinic in South Australia for AUD 5.1 million

Healthia Limited (ASX:HLA) acquired 12 Clinics of The Foot and Ankle Clinic in Melbourne and regional Victoria for AUD 5 million.

Shareholder Returns

Price Volatility

About the Company

Healthia Limited Fundamentals Summary

46.1x

1.0x

Earnings & Revenue